drugset
drugset / Trial / NCT03905408

Pleurodesis Using Hypertonic Glucose to Treat Post-operative Air Leaks

NCT03905408 ↗

Phase 1 Completed 12 enrolled London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Non-randomizedSequentialOpen-labelTreatment

Summary

The investigators will define the most appropriate safe dose of D50 to heal air leaks in patients that have undergone lung resection surgery

Timeline

Start
2019-09-17
Primary completion
2021-02-01
Completion
2021-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucose Unknown 50 ml Other
Subject Glucose Unknown 100 ml Other
Subject Glucose Unknown 150 ml Other
Subject Glucose Unknown 200 ml Other

Indications

No indication recorded.